CADScor® System, a point-of-care diagnostic aid for coronary artery disease (CAD), has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP), clearing the way for commercial availability across the UAE.
The technology uses highly sensitive acoustic signals, computational analysis and artificial intelligence to assess coronary blood flow and help rule out significant coronary artery disease in patients experiencing chest pain or shortness of breath.
The system provides a patient-specific result in less than 10 minutes, potentially supporting faster risk assessment and reducing reliance on more invasive or costly downstream testing.
Click here to join our WhatsApp channel here
The UAE approval also marks the technology’s entry into the Gulf region, with the country positioned as a potential base for wider expansion across the GCC.
“Coronary artery disease is a leading health burden across the Gulf, and the diagnostic pathway remains longer and more resource-intensive than it needs to be,” said Aamir Mahmood, President & CEO of Acarix. “Bringing the CADScor System to the UAE gives frontline clinicians a fast, non-invasive way to rule out CAD at the point of care. This matters for the patients and clinicians we serve.”
The system will be introduced in the UAE through UniTech Solutions, which will handle distribution, clinical support and account development.
The approval comes as healthcare systems increasingly seek rapid, non-invasive diagnostic technologies that can improve patient triage, support clinical decision-making and reduce pressure on cardiac imaging and catheterisation services.
Also read: Connected Care Cooperation Expands to Advance Hospital-at-Home Services Globally
“Entering the UAE is a deliberate step in our strategy to establish the CADScor System as a first-line diagnostic aid in high-value markets,” said Beji George, Head of Global Strategy at Acarix. “The market has the infrastructure, the case volume, and the appetite for technology that improves the pathway, and it gives us a strong base to build from across the region.”
“We are proud to bring the CADScor System to healthcare providers across the UAE,” said Majed Aboalazm, Chief Executive Officer of UniTech Solutions. “It addresses a clear unmet need, giving clinicians a rapid, reliable way to rule out coronary artery disease early in the pathway. We look forward to working alongside Acarix to put it into the hands of cardiologists and emergency teams.”
